SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-21-011100
Filing Date
2021-11-17
Accepted
2021-11-17 20:19:15
Documents
1
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 6273
  Complete submission text file 0001062993-21-011100.txt   7767
Mailing Address 1000 SECOND AVENUE SUITE 3700 SEATTLE WA 98104
Business Address
McIlwain Matthew S (Reporting) CIK: 0001381752 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 211422272

Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments